Table 1.
Clinical parameters for patients and healthy blood donors
| Sex | HBV DNA (copies/ml) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subjects | Male | Female | Age (years) | ALT (U/l) | AST (U/l) | ND | < 103 | 103−107 | > 107 |
| Normal1 | 12 | 8 | 29·1 ± 6·8 | – | – | 20 | 0 | 0 | 0 |
| AHB2 | 7 | 5 | 33·1 ± 5·8 | 729·1 ± 122·7 | 878·1 ± 94·8 | 3 | 4 | 5 | 0 |
| CHB, E+3 | 26 | 18 | 37·7 ± 9·3 | 188·4 ± 52·6 | 144·7 ± 59·6 | 4 | 9 | 20 | 11 |
| CHB, E–4 | 24 | 11 | 40·4 ± 8·6 | 124·5 ± 40·9 | 133·2 ± 48·6 | 5 | 7 | 18 | 5 |
| ASC5 | 17 | 9 | 27·4 ± 4·9 | < 40 | < 50 | 7 | 9 | 10 | 0 |
1
Healthy blood donor.
2
Acute hepatitis B (early phase) patient.
3
Hepatitis B virus envelope antigen (HBeAg)-positive chronic hepatitis B (CHB) patient.
4
HBeAg-negative CHB patient.
5
Asymptomatic hepatitis B virus (HBV) carrier.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ND, not detected.